| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |